Ann: Half Yearly Report and Accounts, page-8

After this I am going dark
Before Dec 11 PBT was an intelligent in their field small biotech investigating PBT434 on a scheduled basis and probably worth 4c.
Then the Doherty et al. discovery, potentially highly valuable to it's owner(s), the argument of what part from 100% of the discovery  the interested parties owned began.
The argument as to who owns what involves lawyers, whose two major appetites are money and time and plenty of both.
Whatever the result to PBT, any ownership, all or part, of the discovery will be an add to the 4c price.
I believe in fairy tales and this could be a good one in time.